Sample B G8
Date: 01-Feb-2011: Monday [Tuesday]
To,
Dr. Narendran
Director, Indian Medicine (Siddha) College,
Chennai, Tamilnadu
Subject[:Recommendation on] Response to Dr. Ramkumar[‘]s request for the application for the intellectual property rights for the new cardiovascular product for coronary atherosclerosis. [Subject is too long, it needs to be brief]
Dear Sir,
Herein [I or We have] attached the report recommending [the most appropriate decision among] the various options available for [to address Dr. Ramkumar’s request for] the Pharmacology Department’s new cost-effective herbo-mineral Siddha non-invasive cardiovascular product for the treatment of Coronary Atherosclerosis The document covers the identification of the key issue, options available and the various methods to handle them [what]. The options are evaluated [against a set of criteria] using all the possible outcomes and the best option and action plan is proposed for further consideration.
Please feel free to contact us regarding any clarifications [required] or corrections [Is it needed?] in the contents of this document. [This statement is not required]
Thank you for giving us this opportunity to work on this project.
Regards,
PQR
Executive Summary:
Dr. Ramkumar, Head of pharmacology department at IMC requested to file an application for intellectual property rights for the cost-effective herbo-mineral Siddha non-invasive cardiovascular product for coronary atherosclerosis and commercialise the formulation.
The various possible options available to the Director of IMC are studied and the [a] detailed analysis with the benefits and shortfalls for each option are provided [described] in this report.
As [The] basis of the analysis for the options are
i. Profitability (Profit margin) ii. Employee engagement (Employee happiness) [both are not same] iii. Benefits to the patients
After the complete analysis [,] Option 3 is recommended and the required action plans [is detailed] are provided for the
To,
Dr. Narendran
Director, Indian Medicine (Siddha) College,
Chennai, Tamilnadu
Subject[:Recommendation on] Response to Dr. Ramkumar[‘]s request for the application for the intellectual property rights for the new cardiovascular product for coronary atherosclerosis. [Subject is too long, it needs to be brief]
Dear Sir,
Herein [I or We have] attached the report recommending [the most appropriate decision among] the various options available for [to address Dr. Ramkumar’s request for] the Pharmacology Department’s new cost-effective herbo-mineral Siddha non-invasive cardiovascular product for the treatment of Coronary Atherosclerosis The document covers the identification of the key issue, options available and the various methods to handle them [what]. The options are evaluated [against a set of criteria] using all the possible outcomes and the best option and action plan is proposed for further consideration.
Please feel free to contact us regarding any clarifications [required] or corrections [Is it needed?] in the contents of this document. [This statement is not required]
Thank you for giving us this opportunity to work on this project.
Regards,
PQR
Executive Summary:
Dr. Ramkumar, Head of pharmacology department at IMC requested to file an application for intellectual property rights for the cost-effective herbo-mineral Siddha non-invasive cardiovascular product for coronary atherosclerosis and commercialise the formulation.
The various possible options available to the Director of IMC are studied and the [a] detailed analysis with the benefits and shortfalls for each option are provided [described] in this report.
As [The] basis of the analysis for the options are
i. Profitability (Profit margin) ii. Employee engagement (Employee happiness) [both are not same] iii. Benefits to the patients
After the complete analysis [,] Option 3 is recommended and the required action plans [is detailed] are provided for the